spacer
spacer

PDBsum entry 4i0s

Go to PDB code: 
protein ligands links
Transferase/transferase inhibitor PDB id
4i0s

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
267 a.a.
Ligands
1B5
Waters ×106
PDB id:
4i0s
Name: Transferase/transferase inhibitor
Title: Crystal structure of spleen tyrosine kinase complexed with 2-(6- chloro-1-methyl-1h-indazol-3-yl)-5h-pyrrolo[2,3-b]pyrazine-7- carboxylic acid isopropylamide
Structure: Tyrosine-protein kinase syk. Chain: a. Fragment: protein kinase domain (unp residues 356-635). Synonym: spleen tyrosine kinase, p72-syk. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: syk. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108.
Resolution:
1.98Å     R-factor:   0.218     R-free:   0.236
Authors: A.Kuglstatter,M.Slade
Key ref: F.Padilla et al. (2013). Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors. J Med Chem, 56, 1677-1692. PubMed id: 23350847 DOI: 10.1021/jm301720p
Date:
19-Nov-12     Release date:   30-Oct-13    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P43405  (KSYK_HUMAN) -  Tyrosine-protein kinase SYK from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
635 a.a.
267 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.2  - non-specific protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1021/jm301720p J Med Chem 56:1677-1692 (2013)
PubMed id: 23350847  
 
 
Pyrrolopyrazines as selective spleen tyrosine kinase inhibitors.
F.Padilla, N.Bhagirath, S.Chen, E.Chiao, D.M.Goldstein, J.C.Hermann, J.Hsu, J.J.Kennedy-Smith, A.Kuglstatter, C.Liao, W.Liu, L.E.Lowrie, K.C.Luk, S.M.Lynch, J.Menke, L.Niu, T.D.Owens, C.O-Yang, A.Railkar, R.C.Schoenfeld, M.Slade, S.Steiner, Y.C.Tan, A.G.Villaseñor, C.Wang, J.Wanner, W.Xie, D.Xu, X.Zhang, M.Zhou, M.C.Lucas.
 
  ABSTRACT  
 
We describe the discovery of several pyrrolopyrazines as potent and selective Syk inhibitors and the efforts that eventually led to the desired improvements in physicochemical properties and human whole blood potencies. Ultimately, our mouse model revealed unexpected toxicity that precluded us from further advancing this series.
 

 

spacer

spacer